The fungus Aspergillus tubingensis (strain OY907) was isolated from the Mediterranean marine sponge Ircinia variabilis. Extracellular extracts produced by this strain were found to inhibit the growth of several fungi. Among the secreted extract components, a novel anhydride metabolite, tubingenoic anhydride A (1) as well as the known 2-carboxymethyl-3-hexylmaleic acid anhydride, asperic acid, and campyrone A and C were purified and their structure elucidated. Compound 1 and 2-carboxymethyl-3-hexylmaleic acid anhydride inhibited Neurospora crassa growth (MIC = 330 and 207 μM, respectively) and affected hyphal morphology. We produced a N. crassa mutant exhibiting tolerance to 1 and found that a yet-uncharacterized gene, designated mas-1, whose product is a cytosolic protein, confers sensitivity to this compound. The ∆mas-1 strain showed increased tolerance to sublethal concentrations of the chitin synthase inhibitor polyoxin D, when compared to the wild type. In addition, the expression of chitin synthase genes was highly elevated in the ∆mas-1 strain, suggesting the gene product is involved in cell wall biosynthesis and the novel anhydride interferes with its function.
pathogenicity of fungal species makes it an attractive target for antifungals, especially due to the fact that some of the constituents of the fungal cell wall are not present in potential hosts [22] . Examples of fungal cell wall biosynthesis inhibitors include the peptide nucleoside antibiotics (polyoxins and nikkomycins) used to inhibit chitin synthases [23, 24] as well as glycolipid papulacandins [25, 26] and lipopeptide echinocandins [27] which block glucan synthesis.
In this study, we report on a novel metabolite, 1, produced by an A. tubingensis strain isolated from the sponge Ircinia variabilis. This metabolite exhibits anti-fungal activity, resulting in the impairment of cell wall integrity. Furthermore, we have determined that sensitivity to this compound can be conferred by a single novel protein in Neurospora crassa designated MAS1. Additional metabolites, the known 2-carboxymethyl-3-hexylmaleic acid anhydride [3] , asperic acid [18] , and campyrone A and C [28] , were purified and their structures elucidated.
Results and Discussion

A Marine-Derived Aspergillus tubingensis Produces Novel Antifungal Compounds
Paz et al. [29] , identified 25 Eurotiales (Aspergillus and Penicillium spp.) associated with the marine sponge Ircinia variabilis. We further analyzed strain OY907 and based on partial sequence of the β-tubulin gene used for identification of Aspergillus species [30] , we have now identified it as Aspergillus tubingensis (Accession number KM079500).
Aspergillus species are widespread among marine sponges and usually constitute a large number of the total fungi isolated from many of these organisms [31] . Holler et al. ] 2 [ found that out of more than 680 fungal strains isolated worldwide from 16 sponge species, the majority belonged to the genera Aspergillus and Penicillium. The high occurrence of these genera was also evident in the report by Paz et al. [29] stating that 25 from a total of 80 Ascomycota taxa isolated from a Mediterranean sponge were Aspergillus and Penicillium spp. Similarly, among culturable fungi from two South China Sea sponges (Clathrina luteoculcitella and Holoxea sp.), these genera were also highly prevalent [32] . Although the genus Aspergillus has been widely investigated, to the best of our knowledge this is the first report of an A. tubingensis that has been isolated from a marine environment.
The specific A. tubingensis strain studied here (OY907) was found to secrete chemicals that inhibited the growth of three test fungi: Alternaria alternata, Rhizoctonia solani and Neurospora crassa, as determined by dual culture diffusion assays (inhibition zones wider than 15 mm from the source in the assay Petri dish). The former are Ascomycete and Basidiomycete plant pathogens, respectively, and the latter is a model Ascomycete which is highly amenable to genetic analysis and manipulation.
We examined, in more detail, the morphological effects of the extract secreted by strain OY907 on N. crassa. When grown in the presence of 2 mg/mL of the crude extract, hyphae of N. crassa exhibited swollen tips with multiple foci of cytoplasmic leakage. Furthermore, significant amounts of amorphous material accumulated along the hyphae ( Figure 1A,B) . A similar phenotype was observed in A. alternata, but not in R. solani (where the inhibition of radial growth was not accompanied by this morphological defect). As the outcome of exposure to the extract could involve more than one compound, fractionation and subsequent structure elucidation of antifungal compounds produced by this strain were carried out.
Tubingenoic anhydride A (1; Figure 2 ) was isolated as a colorless oil that presented a negative HRESIMS pseudo-molecular ion at m/z 195.1024 corresponding to the molecular formula C 11 H 16 O 3 and four degrees of unsaturation. Its 1 H NMR spectrum (CDCl 3 + CD 3 OD) presented two singlet protons at 6.34 and 5.72 ppm, a triplet proton at 3.40 ppm, two protons at 1.83 and 1.62 ppm, a 8H-multiplet at 1.24 ppm and a triplet methyl at 0.82 ppm. Based on the HSQC experiment, the 13 C NMR spectrum of 1 presented four sp 2 carbons (176.0 s, 168.7 s, 138.5 s and 127.2 t), a methine carbon (46.6 ppm), five methylene carbons (30.8, 31.4, 29 .0, 27.3 and 22.4 ppm) and a methyl carbon (13.8 ppm) . Correlations from the COSY experiment allowed the connection of the methine H-3 (3.40 ppm) with the protons of the diastereotopic methylene-1′ (1.82 and 1.61 ppm) and of the later with the eight-proton multiplet at 1.24 ppm. This multiplet was further correlated with the triplet methyl suggesting that a normal hexyl was attached to methine-3. This was supported by the HMBC correlations summarized in Table 1 . Additional long-range COSY correlation of H-3 with the singlet proton at 5.71 ppm and of the later with the singlet proton at 6.34 ppm, both belonging to a terminal methylene (1″) based on the HSQC spectrum ( Table 1) , suggested that H-3 is allylic to the terminal methylene. The chemical shift of the terminal methylene protons, suggested their conjugation to a carbonyl as was evident from their strong ( Tubingenoic anhydride A (1) is a polyketide metabolite exhibiting anti-fungal activity (N. crassa MIC = 330 μM) derived from the conjugation of octanoic acid and C 4 metabolite, probably oxaloacetic acid and decarboxylation. Related metabolites were previously isolated from several Aspergillus spp.
2-Carboxymethyl-3-hexylmaleic acid anhydride was isolated from Aspergillus awamori as a weak antibiotic of gram-positive bacteria [33] . We found this compound to also exhibit an inhibitory effect on N. crassa (MIC = 207 μM). 2-Carboxymethyl-3-hexylmaleic acid anhydride and 2-methylene-3-hexylbutanedioic acid were isolated from A. niger as enhancers of seed germination, and shoot and root growth in cauliflower seedlings [34] . Related metabolites were characterized from other fungi, lichen [35] and plants [36] . The fact that compounds related to the metabolites described here affect the growth of a variety of organisms may have implications concerning the compounds described here. The growth promotion and/or inhibitory effects these compounds may have on the microbiota of the sponge, or the sponge itself, may prove to have ecological significance if they are also produced in the sponge holobiont.
mas-1 Is a Novel N. crassa Gene Conferring Sensitivity to Antifungal Compounds Produced by A. tubingensis Strain OY907
In order to provide insight on the mechanism(s) involved in conferring sensitivity of N. crassa to the secreted antifungal metabolites produced by strain OY907, a genetic approach was employed. The wild type strain was subjected to tagged insertional mutagenesis with the use of plasmid pNV15 which harbors a Nourseothricin (NAT) resistance cassette. The Nat R transformants were examined for resistance to the antifungal compounds. Analysis of progeny from purified homokaryons crossed to the wild type confirmed the genetic link between Nat R and the ability to grow on the crude extract. One of the transformants (m-42) was used for further analysis. To determine the integration site of the pNV15 construct, DNA contiguous with the inserted plasmid was retrieved by a plasmid rescue procedure. Genomic DNA of the resistant mutant was digested with BamHI (which does not cleave within the mutagenesis plasmid) and the ligated product was sequenced. DNA sequence flanking the pNV15 insert was then used to probe the N. crassa genome database [37] The disrupted locus was found to be a new gene (NCU03140) that encodes for a yet uncharacterized, small (91 aa), hypothetical protein ( Figure 3A ) whose disruption does not result in any observable defect under standard growth conditions. Since there were no homologs to this gene in other fungi or indications for the presence of a conserved motif in the NCBI databases, we designated this new gene mas-1 (Marine-Aspergillus Sensitive 1). Even though the genome of several hundred fungal strains has been sequenced, many genes in the highly diverse members of this kingdom have not been assigned functions. This is also true for N. crassa, the first published full genome of a filamentous fungus [37, 38] , where hundreds of genes have yet to be assigned functions.
As mas-1 is a unique, yet uncharacterized gene, several measures were taken in order to fully confirm the relevance of mas-1 to the sensitivity of N. crassa to the A. tubingensis metabolites. To verify that no annotation error (resulting in miscall of the small mas-1 gene) had occurred during the analysis of the N. crassa genome, we examined the ∆mas-1 (NCU03140) deletion strain obtained from the FGSC and compared it to strain m-42. As both strains were resistant to the antifungal extract, we concluded that mas-1 is, indeed, involved in conferring the biological activity of the A. tubingensis metabolites to N. crassa ( Figure 3B ). In additional experiments, when tested on medium amended with the purified novel tubingenoic anhydride A (1), the wild type was highly sensitive to the metabolite compared to the ∆mas-1 strain, at a concentration of 0.8 mg/mL. When conidia of the ∆mas-1 strain were placed on medium amended with the A. tubingensis extract, they germinated to produce normal appearing hyphae, with the exception of a few cases of hyphal swelling and cytoplasmic leakage. Hence, even though the absence of mas-1 confers a high degree of tolerance to the crude extract, at concentrations of 2 mg/mL or higher, some effects of the antifungal compound could still be observed (Figure 4 ), indicating that mas-1 is not the only gene involved in conferring the effects of the antifungal compound. Otherwise, deletion of mas-1 did not affect the fitness of N. crassa in terms of growth rate and amount and types of conidia (data not shown). 
A B
As mas-1 is a small gene and is closely linked to two additional genes: Histidine biosynthesis trifunctional protein (his-3; NCU03139) and Lysophospholipase (NCU03141) (Figure 4A ), that may have been affected by the mutagenesis procedure (in either or both resistant strains), we performed genetic complementation by introducing a wild-type copy of mas-1 into the m-42 mutant. To do so, we transformed the mutant with pLK2, containing a wild type copy of the mas-1 gene and cotransformed the m-42 strain along with a pCSN44 plasmid that contained the hygromycin B resistance gene cassette as a dominant selectable marker [39] . Hyg R transformants were tested for their sensitivity to the A. tubingensis crude extract. All transformants tested regained sensitivity to the crude extract (albeit at different levels, possibly due to the locus of pLK2 integration) ( Figure 5 ). Taken together, our results confirmed that an intact mas-1 does, indeed, confer sensitivity of N. crassa to the crude extract produced by the marine-derived A. tubingensis. 
Lack of mas-1 Increases the Resistance of N. crassa to Polyoxin D
As the nature of the phenotypic consequences in the presence of the A. tubingensis extract indicated that hyphal integrity may be compromised, we analyzed the sensitivity of the ∆mas-1 strain to several fungicides whose function results in impaired hyphal integrity. Sublethal concentrations of Fluconazole (an ergosterol biosynthesis inhibitor) or fludioxonil (an activator of the hyperosmotic stress response pathway) did not differentially affect the growth of mas-1 when compared to the wild type ( Figure 6 ). However, when grown in the presence of the chitin synthase inhibitor polyoxin D, the ∆mas-1 strain was only about half as sensitive when compared to the wild type (26% and 53% inhibition of radial growth in the presence of 40 M of the drug, respectively). These data suggest that the chitin constituent of the cell wall may be compromised in a ∆mas-1 background. Furthermore, the fact that the increased tolerance of the ∆mas-1 strain to Polyoxin D was not accompanied by a similar trend when exposed to the glucan synthesis inhibitor caspofungin, suggests that the functional link of MAS1 to chitin biosynthesis is specific. Alternatively, the lack of MAS1 may also affect chitin synthesis in an indirect manner, e.g., via altering the capacity of the fungus to uptake the chitin synthase inhibitor. Regardless of the precise mechanism involved, the interest in all aspects of fungal cell wall integrity as a potential target for antifungals [40, 41] warrants additional functional analysis of the novel compound described as well as the role mas-1 (or functional counterparts in other fungi) play in maintenance of fungal cell integrity. The cross-species sensitivity and the similar defects in the test fungi analyzed on the one hand, and the fact that mas-1 is a unique gene, on the other, suggest that other genes in A. alternata and R. solani (and likely in N. crassa as well) are involved in conferring sensitivity/tolerance to the newly identified compound. Analysis of addition N. crassa mutants tolerant to the compound as well as further analysis of the other test fungi may provide a better mechanistic understanding of the compounds' mode of action. Such information has the potential to be utilized in the development of antifungal treatments based on cell wall impairment as a target. 
Chitin Synthase Gene Expression Is Altered in Response to the A. tubingensis Extract
To provide additional insight as to the link between the A. tubingensis antifungal products and cell wall integrity, we examined the relative expression of the seven chs genes in the wild type and in ∆mas-1. When exposed to a sublethal concentration (1 mg/mL) of the A. tubingensis crude extract, a significant increase in the transcript levels of all chs genes was observed in the wild type strain (Figure 7) , an expected cellular response to perturbation of cell wall integrity (with emphasis on the chitin component). The extent of that response was less pronounced in the ∆mas-1 strain. However, chs genes expression in the mutant was approx. two-fold higher than in the wild type to begin with (in the absence of the extract). These higher expression levels include chs-4, a gene whose product has been implied to be an "auxiliary enzyme" under stressful conditions [42] . It is tempting to speculate that the lack of mas-1 confers a precondition in which the fungal cell has an elevated pool of chitin synthases that contributes to its tolerance to the A. tubingensis products. Even though exposure to sublethal A. tubingensis extract concentrations results in increased chs expression in the wild type, the expression levels may not be sufficient to confer tolerance once the fungus has been exposed to the antifungal compounds. It is also possible that MAS1 functions in additional manners that increase tolerance, such as an effect on chitin synthase localization/activation or via additional components involved in cell wall integrity. Overall, these results indicate that the A. tubingensis crude extract has an effect on chs genes expression and that at least part of the changes in chs genes expression is mediated by MAS1. Figure 7 . Relative expression levels of seven chitin synthase genes in N. crassa wild type and ∆mas-1 grow on non-amended and extract-amended (1 mg/mL, a sub lethal concentration) media, as determined by Real Time PCR. RNA was extracted from conidial germlings and expression was normalized using the beta tubulin gene. Relative expression levels were calculated using the 2 −Δct method.
Cellular Localization of MAS1::GFP
In order to determine the cellular localization of MAS1, we constructed a MAS1::GFP fusion (designated pLK4) driven by the N. crassa inducible ccg-1 promoter pMF272 [43] . The ∆mas-1 strain was co-transformed with pLK4 and pNV15 (conferring NAT R ). The resulting transformants restored sensitivity to the crude extract, verifying the functionality of the MAS1::GFP fusion insert. Western blot analysis using anti-GFP antibodies was used to verify the presence of tagged MAS1. Confocal microscopy indicated that MAS1::GFP is distributed throughout the hyphal cell in a punctate manner, with marked presence of the protein in yet unidentified round organelles (Figure 8 ). These bodies accumulated especially at the hyphal apex. When grown on the presence of the A. tubingensis crude extract, no detectable change in MAS1::GFP localization was observed. Our results suggest that MAS1 is a cytosolic protein that accumulates (or is ferried) in specific cellular compartments. Furthermore, MAS1 was not detected in conidia. Though some chitin synthases are ferried in distinct vesicles [44] , the pattern observed here was different from the distribution patterns characteristic of chitosomes [45] . In summary, marine sponge-associated fungi have a great potential to be a rich source of promising antifungal compounds, and this may be due, in part, to the unique ecological grow conditions (including the presence of additional, competing, fungi in this exceptional niche). Even though the compounds described have relatively high MICs, the potential of combining these or structurally related compounds with more effective antifungals (cell wall inhibitors or others) may provide an additional basis for antifungal intervention. The abundance of resources available for the analysis of N. crassa provides an attractive platform for the analysis of the mode of action of novel compounds as a step in the development of antifungal strategies.
Experimental Section
General Experimental Procedures-Chemical Analysis
Optical rotation values were obtained on a Jasco P-1010 polarimeter at the sodium D line (589 nm). UV spectra were recorded on an Agilent 8453 spectrophotometer. High-resolution MS were recorded on a Waters MALDI Synapt instrument. NMR spectra were recorded, at 25 °C, on a Bruker DRX-500 spectrometer at 500.13 MHz for 1 H and 125.76 MHz for 13 C. COSY-45, gTOCSY, gROESY, gHSQC and gHMBC spectra were recorded using standard Bruker pulse sequences. HPLC separations were performed on a Jasco HPLC system (model PU-2080-plus pump, model LG-2080-04 Quaternary gradient unit and model MD-2010-plus Multi-wavelenght detector) and on an Agilent 1100 series HPLC system.
Fungal Strains, Media, and Growth Conditions
An Aspergillus sp. strain (OY907) previously isolated from the Mediterranean sponge Ircinia variabilis (formerly designated as a Psammocinia sp. Paz et al. [29] ) was cultured either on Potato Dextrose Agar (PDA; Difco) or mass cultivated in 1 L stationary flasks containing 200 mL Potato Dextrose Broth (PDB; Difco) for 25 days at 27 °C in the dark. Alternaria alternata (Aa01) and Rhizoctonia solani (TP6) form the Department of Plant Pathology and Microbiology collection were maintained on PDA. N. crassa strains used in this study were the wild type (74-OR23-1A), a mas-1 N. crassa knock out mutant strain (FGSC14039; NCU03140), as well as chs-1, -3,-4,-5,-6 and 7, which were obtained from the Fungal Genetic Stock Center. The chs-2 RIP strain was described in a previous study [46] . N. crassa strains were grown in either liquid or solid (supplemented with 1.5% agar) Vogel's minimal medium supplemented with 1.5% (w/v) sucrose (Vs). Unless stated otherwise, all growth and manipulations of N. crassa were as previously described [47] . When required, the medium was supplemented with 100 μg/mL hygromycin B (Calbiochem, Riverside, CA) or 20 μg/mL nourseothricin (Werner Bioagents, Jena, Germany). Fungicides used in this study were: fluconazole (Orius, Makhteshim-Agan) which is an ergosterol biosynthesis inhibitor, fludioxonil (Fluka analytical, Sigma Aldrich) an activator of the hyperosotic stress response pathway, caspofungin, a (1→3)-β-D-glucan synthase inhibitor (Merck Research Laboratories, Rahway, NJ, USA) and polyoxin D (Kaken Chemical Company, Tokyo, Japan) a chitin synthase inhibitor. For growth rate measurements, 10 μL of a conidial suspension (1 × 10 7 conidia/mL) were inoculated on Petri dishes or race tubes containing Vs and growth was measured periodically.
Antifungal Activity Assays
To determine the presence of secreted anti-fungal compounds, an agar medium diffusion assay was performed using N. crassa, A. alternata and R. solani [48] . A mycelial disk of strain OY907 was placed in the center of a petri dish containing PDA and disks of the test fungi were placed on the Petri dish periphery. Following 3 or 14 days of incubation (to test the effects on N. crassa and the other two fungi, respectively), the effect of diffused compounds from the marine isolate was assessed. The formation of inhibition zones wider than 15 mm between the OY907 source and the test organisms was considered as an indicator for the presence of inhibitory compounds.
Chemical Analysis of the Antifungal Product
Strain OY907 was mass cultivated on PDB in stationary flasks for 25 days at 27 °C in the dark. The mycelium was separated from the growth medium by filtration and then extracted two times with ethyl acetate 1:1 (v:v). Ethyl acetate extracts were combined, filtered and evaporated. The dry crude extract was dissolved in dimethylsulfoxide (DMSO) and tested for its antifungal activity. The extract was fractionated on a reversed-phase open column followed by gel-filtration on Sephadex LH-20. Each fraction was tested for biological activity by amending the N. crassa growth medium with a range of concentrations (0.5-2 mg/mL) of the dried fraction. Final purification of the active (antifungal) compounds was achieved by HPLC separation. The active fraction was retested for antifungal activity and the structure of the purified compound was elucidated by1D and 2D NMR technique and HR mass spectrometry. 
Disruption of mas-1
In order to study the function of the A. tubingensis secreted metabolites, a N. crassa resistance mutant was produced by random tagged insertional mutagenesis by electroporation [49] . We used plasmid pNV15 which harbors a Nourseothricin (NAT) resistance cassette [50] that linearized by SacI and subjected to wild type. The inserted plasmid was retrieved following a plasmid rescue procedure [51] . Genomic DNA of the resistant mutant was digested with BamHI. The digested products were subsequently subjected to ligation (T4 ligase Thermo scientific) in a 100 µL reaction volume. The ligated products were then cloned into E. coli HIT DH5α competent cells (RBC Bioscience) and resulting clones were sequenced.
Functional Complementation
For introducing a wild-type copy of mas-1 into the m42 mutant, the mas-1 gene was amplified by using primers f-1200 and r-609 that include the mas-1 gene as well as 1200 bp and 609 bp of DNA upstream and downstream of the coding region, respectively. The PCR product was cloned into a pDRIVE expression vector (QIAGEN) according to the manufacturer's instructions and designated pLK3. pLK3 was restricted with StuI and the linear construct was cotransformed into the N. crassa m-42 strain along with pCSN44 (which contains a hygromycin B resistance cassette) [39] . The resulting transformants were tested for their ability to grow on hygromycin B and for sensitivity to the crude extract from the A. tubingensis growth medium. PCR amplification of the inserted cassette utilizing primers hphf and hphr and primers mas-1f and mas-1r (Table 2) , were used to verify insertion of the pLK3 plasmid and the pCSN44 plasmid into m-42 mutant.
Chitin Synthase Gene Expression
N. crassa has been shown to have seven genes encoding chitin synthases [38] . In order to determine whether deletion of mas-1 conferred changes in the expression of the different chitin synthase (chs) genes, we preformed Real Time PCR for all the seven chs genes. Since genes encoding for CHS in N. crassa are highly similar, manual primer design was carried out in order to identify unique 80-150 bp amplicons. Confirmation of primer set specificity was performed by Real Time PCR on cDNA templates of the mutants lacking genes encoding for CHS.
For determining chs gene expression, RNA was extracted from conidial germlings (from the wild type and ∆mas-1 strains) that were grown on liquid Vs amended with 1 mg/mL (a sub lethal concentration) of the crude extract for 4 h at 34 °C at 150 rpm. The RNA samples were purified with the RNeasy Plant Mini Kit (Qiagen) as previously described [47] . Purified RNA (1 μg) was used for the RT procedures using SuperScript II RNase H reverse transcriptase (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Relative quantification of transcript abundance of the 7 chs genes was performed on an ABI StepOnePlus Real-Time PCR Sequence Detection System and software (Applied Biosystems) as described [52] . RT-PCR mixtures were comprised of a 3.3 µM concentration of each primer (see Table 2 ), 5 μL of SYBR green PCR master mix (Applied Biosystems), 2 μL of cDNA at concentration of 10 ng, and nuclease-free water to a final volume of 10 μL. The annealing temperature was modified to 64 °C, utilizing chs 1-7 primers (see Table 2 ). Total cDNA abundance in the samples was normalized using the beta tubulin gene (NCU04173.3) . In all experiments, samples were amplified in triplicate, and the average cycle threshold was then calculated and used to determine the relative expression of each gene. Relative expression levels were calculated using the 2 −Δct method [53] . Table 2 . Primers used in this study.
MAS1::GFP Fusion Protein Construct and Confocal Imaging
In order to monitor the protein in vivo for cellular localization, MAS1 was tagged with a green fluorescent protein (GFP). The putative mas-1 ORF (381 bp) was amplified, without the stop codon, as an XmaI/XbaI fragment (390 bp) utilizing primers gfp-1f and gfp-1r (Table 2 ) and cloned into a pDrive vector (Qiagen) to yield pLK1. The pLK1 insert, retrieved following XmaI/XbaI restriction and gel purification, was ligated into an XmaI/XbaI digested pMF272, a sgfp plasmid driven by the N. crassa ccg-1 promoter (AY598428) [43] which is induced by glucose deprivation or stress [54] . This yielded pLK2, an expression plasmid used for MAS1 localization and for complementation of the mas-1 strain. pLK2 was digested with SapI/PstI and the gel-purified fragment (4 kb) was used to cotransform the mutant strain along with pNV15. The transformed isolates were selected for their ability to grow on NAT. PCR amplification and subsequent sequencing of pLK2 utilizing primers gfp-2f and gfp-2r (Table 2) , were performed to verify insertion of the pLK2 plasmid into mas-1. In addition, primers nat-1f and nat-1r (Table 2 ) were used to verify the presence of the pNV15 insert. Transformant homokaryons were purified by isolation of microconidia. The GFP-expressing strains were first grown on Vogel's medium with 2% glucose for 18 h at 34 °C, then, harvested, washed with water and resuspended in Vogel's minimal medium with no carbon source for an additional 2 h. The presence of the MAS1::GFP fusion protein was determined by western blot analysis as described [55] . Primary antibodies used were mouse anti-GFP (Covance, Princeton, NJ, USA) followed by goat anti-mouse secondary antibodies (Amersham Biosciences, Freiburg, Germany). For cellular localization, confocal laser scanning inverted microscopy was performed using a LEICA TCS SP8 system equipped with an argon ion laser. The strains were imaged by excitation with the 488 nm laser line and emission at 510-530 nm. Oil immersion 60× or dry 20× lenses were used for imaging.
Conclusions
In this study, we have identified a fungal strain previously isolated from the Mediterranean marine sponge Ircinia variabilis as Aspergillus tubingensis. We have purified and identified a novel compound that exhibits antifungal properties and have identified it as Tubingenoic anhydride A. We have determined that a small (91 aa), yet uncharacterized protein, MAS1, confers sensitivity to the antifungal products in N. crassa. The Δmas-1 strain was two-fold more resistant to the chitin synthase inhibitor Polyoxin D than the wild type, suggesting, that the mas-1 gene is involved in the cell wall integrity. Moreover, the constitutive elevated expression of chitin synthase genes in the Δmas-1 mutant supports the link of MAS1 to cell wall integrity.
